MARKET

ONVO

ONVO

Organovo Holdings
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.49
-0.09
-1.05%
Closed 17:28 06/23 EDT
OPEN
8.55
PREV CLOSE
8.58
HIGH
8.63
LOW
8.21
VOLUME
104.89K
TURNOVER
--
52 WEEK HIGH
23.92
52 WEEK LOW
6.02
MARKET CAP
73.85M
P/E (TTM)
-3.4061
1D
5D
1M
3M
1Y
5Y
/C O R R E C T I O N from Source -- RBC Global Asset Management Inc./
RBC Global Asset Management Inc. ("RBC GAM Inc.") today announced June 2021 cash distributions for unitholders of RBC ETFs, as follows:
CNW Group · 1d ago
Is Organovo Holdings Inc (ONVO) A Good Stock To Buy?
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious towards the current bull run since March, 2020 an...
Insider Monkey · 06/15 15:38
Asensus Surgical to join Russell Microcap Index, while Sorrento Therapeutics to see deletion
At the conclusion of the 2021 Russell indexes annual reconstitution, following notable healthcare stocks will join the Russell Microcap Index, effective June 28 after the U.S. market opens.Asensus Surgical (ASXC), Organovo
Seekingalpha · 06/14 19:29
Organovo Holdings Granted European Patent Titled 'AUTOMATED DEVICES, SYSTEMS, AND METHODS FOR THE FABRICATION OF TISSUE'
https://register.epo.org/application?number=EP14832338
Benzinga · 06/01 19:13
44 Biggest Movers From Friday
Gainers
Benzinga · 06/01 09:21
ONVO, YEXT, CTRM and SLCA among midday movers
Gainers: SemiLEDs (LEDS) +49%.Vertex Energy (VTNR) +45%.Organovo (ONVO) +28%.eMagin (EMAN) +24%.Mannatech (MTEX) +21%.Welbilt (WBT) +21%.Yext (YEXT) +19%.MoSys (MOSY) +16%.Embotelladora Andina (AKO-B) +13%.Iterum Therapeutics (ITRM) +17%.Losers: 1847 Goede...
Seekingalpha · 05/28 16:39
12 Health Care Stocks Moving In Friday's Intraday Session
 
Benzinga · 05/28 16:32
Organovo up 36% on bullish assessment of 3D human tissue biotech
Organovo Holdings (ONVO) has rocketed 36% to $9.80 in afternoon trading after Seeking Alpha contributor Gunner Laine Hardy offered a bullish assessment behind the 3D human tissue biotech.While Hardy cautions the stock
Seekingalpha · 05/28 16:11
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ONVO. Analyze the recent business situations of Organovo Holdings through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ONVO stock price target is 3.000 with a high estimate of 3.000 and a low estimate of 3.000.
EPS
Institutional Holdings
Institutions: 132
Institutional Holdings: 5.31M
% Owned: 61.07%
Shares Outstanding: 8.70M
TypeInstitutionsShares
Increased
9
156.64K
New
11
59.54K
Decreased
9
981.21K
Sold Out
10
60.48K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-0.36%
Pharmaceuticals & Medical Research
-0.51%
Key Executives
Chairman/Chief Executive Officer/Chief Financial Officer/Executive Director
Keith Murphy
President/Chief Financial Officer
Jonathan Lieber
Chief Scientific Officer
Jeffrey Miner
General Counsel/Secretary
Thomas Jurgensen
Other
Steven Hughes
Independent Director
Douglas Cohen
Independent Director
David Gobel
Independent Director
Alison Milhous
Independent Director
Adam Stern
No Data
About ONVO
Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products, including 3D human tissues used for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion (ADME), and drug metabolism and pharmacokinetics (DMPK); customized human tissues as living, dynamic models of human biology or disease, for use in drug discovery and development, and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair and functional tissue patches for the repair or replacement of damaged tissues and organs.

Webull offers kinds of Organovo Holdings Inc stock information, including NASDAQ:ONVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONVO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ONVO stock methods without spending real money on the virtual paper trading platform.